Cargando…
NEK2 enhances malignancies of glioblastoma via NIK/NF-κB pathway
Glioblastoma (GBM) is one of the most lethal primary brain tumor with a poor median survival less than 15 months. Despite the development of the clinical strategies over the decades, the outcomes for GBM patients remain dismal due to the strong proliferation and invasion ability and the acquired res...
Autores principales: | Xiang, Jianyang, Alafate, Wahafu, Wu, Wei, Wang, Yichang, Li, Xiaodong, Xie, Wanfu, Bai, Xiaobin, Li, Ruichun, Wang, Maode, Wang, Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760305/ https://www.ncbi.nlm.nih.gov/pubmed/35031599 http://dx.doi.org/10.1038/s41419-022-04512-6 |
Ejemplares similares
-
Retinol binding protein 1‐dependent activation of NF‐ κB signaling enhances the malignancy of non‐glioblastomatous diffuse gliomas
por: Wu, Wei, et al.
Publicado: (2021) -
FABP5 enhances malignancies of lower‐grade gliomas via canonical activation of NF‐κB signaling
por: Wang, Yichang, et al.
Publicado: (2021) -
Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma
por: Alafate, Wahafu, et al.
Publicado: (2020) -
Preoperative Prediction Nomogram Based on Integrated Profiling for Glioblastoma Multiforme in Glioma Patients
por: Wu, Wei, et al.
Publicado: (2020) -
A Novel Multi-Omics Analysis Model for Diagnosis and Survival Prediction of Lower-Grade Glioma Patients
por: Wu, Wei, et al.
Publicado: (2022)